Approval · Notice of Compliance 3880 · 1997
COMBIVENT: Notice of Compliance 3880
Issued July 8, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3880
- Date
- July 8, 1997
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: in plastic single dose units
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBIVENT | 02231675 | Cancelled Post Market |
Medicinal ingredients
- IPRATROPIUM BROMIDE 0.2 MG per ML
- SALBUTAMOL SULFATE 1.2 MG per ML